Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook

Marcelien H.E. Callenbach, Lldikó Ádám, Rick A. Vreman, Bertalan Németh, Zoltán Kaló, Wim G. Goettsch*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

There is growing interest in innovative reimbursement and payment models in Central and Eastern European (CEE) and Middle Eastern (ME) countries. A questionnaire was sent to payers from CEE and ME countries regarding the current use of, future preferences for and perceived barriers with these models. Twenty-seven healthcare payers from 11 countries completed the survey. Results showed participants preferred using outcome-based reimbursement models and delayed payment models more often; however, currently they are rarely applied. Barriers hindering implementation were mostly related to IT and data infrastructure, measurement issues, transaction costs and the administrative burden. Given these barriers highlighted in our study, policymakers should focus on the development of an implementation framework with contract templates for the preferred reimbursement and payment schemes to aid the feasibility of a successful implementation.

Original languageEnglish
Article number103433
Pages (from-to)1-9
Number of pages9
JournalDrug Discovery Today
Volume28
Issue number1
DOIs
Publication statusPublished - 1 Jan 2023

Keywords

  • Central and Eastern Europe
  • Delayed payment
  • Managed entry agreements
  • Middle East
  • Outcome-based reimbursement
  • Pharmaceutical reimbursement

Fingerprint

Dive into the research topics of 'Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook'. Together they form a unique fingerprint.

Cite this